Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

Neurology & Metabolic Disorders

Adepend

Adepend is used as part of a comprehensive programme of treatment against alcoholism to reduce the risk of relapse, as support treatment in abstinence and to reduce the craving for alcohol.

Drug Facts
Active Ingredient
Adepend
Neurology & Metabolic Disorders

Naltrexone hydrochloride

Naltrexone AOP is for use as an additional therapy within a comprehensive treatment program including psychological guidance for detoxified patients who have been opioid-dependent.

Drug Facts
Active Ingredient
Naltrexone hydrochloride
Neurology & Metabolic Disorders

Tardiben®

Tardiben tablets are indicated for both hyperkinetic motor disorders associated with Huntington’s chorea and the treatment of moderate to severe tardive dyskinesia, which is an adverse effect associated with antipsychotic medicines.

Drug Facts
Active Ingredient
Tetrabenazine
Neurology & Metabolic Disorders

Tetrabenazine

Tetrabenazine is used for the treatment of diseases causing jerky, irregular, uncontrollable movements (hyperkinetic motor disorders with Huntington’s chorea).

Drug Facts
Active Ingredient
Tetrabenazine